Crafting Investor-Focused Presentations 📈

SigniGene harnesses the transformative power of pharmacogenomics to optimise personalised medicine, reduce adverse drug reactions, and improve drug efficacy using genetic insights. Our unique PAAS platform integrates seamlessly with Open-EHR systems and offers clinicians actionable data while empowering patients through a dedicated app. With proven success in UK pilots and expanding into Jordan and UAE, SigniGene addresses privacy, education gaps, and market growth, projecting £147M revenue...